Clinical Trial Update: A Clinical Study of iPSC-Derived Islet Cells for Diabetes Mellitus Therapy [NA]

View source ↗

Summary

A clinical study evaluating iPSC-derived islet cells as a therapy for diabetes mellitus, with the trial currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• iPSC-Derived Islet Cells

Snippet

Sponsor: Peking University First Hospital | Conditions: Diabetes Mellitus | NA | Status: NOT_YET_RECRUITING